Thu • Oct
26

Thursday, October 26, 2023

4:00PM-5:00PM

This will be a virtual event. Login information will be included in your confirmation email.

The event is free; advance registration is required.


The New York Academy of Medicine is proud to partner with The Women in Medicine Legacy Foundation to present the Alma Dea Morani Renaissance Woman Award to Nanette K. Wenger, MD, MACC, MACP, FAHA, a Pioneer and Champion of Women's Heart Health.


Through her professional career Nanette K. Wenger, MD, MACC, MACP, FAHA has led to the advancement of knowledge and practice of women's heart health, cardiovascular disease prevention, cardiac rehabilitation, and geriatric cardiology. Although cardiovascular disease is the leading cause of mortality and disease burden for both women and men, disparities persist in the cardiovascular health of women.

Cardiovascular Disease In Women: Epidemiology, Awareness, Access, And Delivery Of Equitable Health Care

During the event, Dr. Wenger’s will deliver remarks outlining the call to action to provide equitable healthcare for women including culturally sensitive education and awareness campaigns for community members, healthcare trainees and clinicians, and other stakeholders. She will discuss how there must be improved access for women to quality healthcare; expanded basic science, clinical, translational, and population research on cardiovascular prevention and treatment for women; and advocacy for public policy and legislative interventions to focus on social determinants of health.

Dr. Wenger will be introduced by the 2008 Alma Dea Morani Renaissance Woman Award recipient, Dr. Ellen R. Gritz.

Join us as we recognize Dr. Wenger’s achievements, as well as the importance of women leaders in medicine.

About the Award
The Alma Dea Morani, MD Renaissance Woman Award recognizes an outstanding contemporary pioneer in the medical sciences. It was named for Alma Dea Morani, MD, the first woman admitted to the American Society of Plastic and Reconstructive Surgeons and an advocate for humanism in medicine. Recipients demonstrate professional excellence, a thirst for knowledge, and service beyond their medical practice or scientific endeavors. Learn more about the award.

About the Women in Medicine Legacy Foundation
The Women in Medicine Legacy Foundation was founded with the strong belief that understanding our history plays a powerful role in shaping our future. The resolute stand women took to establish their place in these fields propels our vision forward. We serve as stewards to the stories from the past and take pride in sharing them with the women of today. Our mission is to preserve and promote the history of women in medicine and the medical sciences, and we look forward to connecting you to our collective legacy that will empower our future. Learn more at www.wimlf.org.


About Nanette K. Wenger, MD, MACC, MACP, FAHA
Dr. Wenger is Professor of Medicine in the Division of Cardiology at the Emory University School of Medicine. She is a Consultant to the Emory Heart and Vascular Center, and Founding Consultant, Emory Women’s Heart Center.

Coronary heart disease in women is one of Dr. Wenger’s major clinical and research interests. She chaired the U.S. National Heart, Lung, and Blood Institute Conference on Cardiovascular Health and Disease in Women. Dr. Wenger has expertise in cardiac rehabilitation. She chaired the World Health Organization Expert Committee on Rehabilitation after Cardiovascular Disease, and co-chaired the Guideline Panel on Cardiac Rehabilitation for the U.S. Agency for Health Care Policy and Research. Dr. Wenger has a longstanding interest in geriatric cardiology, is Past President of the Society of Geriatric Cardiology and was Editor-in-Chief of the American Journal of Geriatric Cardiology for over 15 years.

Read Dr. Wenger’s Full Bio

Dr. Wenger received the Outstanding Professional Achievement Award from Hunter College (1993), the Physician of the Year Award of the American Heart Association (1998), and the Distinguished Achievement Award from the Scientific Councils of the American Heart Association and its Women in Cardiology Mentoring Award (1999). 

In 2000, Dr Wenger was presented the James D. Bruce Memorial Award of the American College of Physicians for distinguished contributions in preventive medicine (2000). In 2002 she received the Distinguished Fellow Award of the Society of Geriatric Cardiology, and was included in the National Library of Medicine Exhibition Changing the Face of Medicine: A History of American Women Physicians (2003). Dr. Wenger received the Gold Heart Award, the highest award of the American Heart Association (2004). 

At the Emory University 2004 Commencement, Dr. Wenger received the Emory Williams Distinguished Teaching Award of the University and the Evangeline Papageorge Alumni Teaching Award of the School of Medicine. Dr. Wenger was selected to deliver the 2004 Laennec Lecture of the American Heart Association. In 2006, Dr. Wenger received the Hatter Award, international recognition for the advancement of cardiovascular science. The Georgia Chapter, American College of Cardiology, presented Dr. Wenger its Lifetime Achievement Award in 2009. She was selected Georgia Woman of the Year for 2010. In 2011, Dr. Wenger was selected to deliver the James B. Herrick lecture by the American Heart Association for her outstanding achievement in clinical cardiology. She was elected a member of Emory’s 175 Historymakers during Emory’s first 175 years.

In 2012, Dr. Wenger received the Charles R. Hatcher, Jr., MD, Award for Excellence in Public Health from Emory University; and was honored in 2013 by establishment of the J. Willis Hurst, R. Bruce Logue, and Nanette K. Wenger Cardiovascular Society for Emory Cardiology Trainee Alumni. In 2013, she received the Inaugural Distinguished Mentor Award of the American College of Cardiology and the Arnall Patz Lifetime Achievement Award of the Emory School of Medicine Medical Alumni Association. The American Society of Preventive Cardiology honored Dr. Wenger by naming an annual Nanette K. Wenger Distinguished Lecture focusing on cardiovascular prevention in women (2014).

In 2015, she was awarded the Inaugural Bernadine Healy Leadership in Women’s CV Disease Award, American College of Cardiology. Dr. Wenger received the Spirit of the Heart Legacy Award of the Association of Black Cardiologists (2017), and was an invited lecturer for the 70th Anniversary NHLBI program in Bethesda, MD (2018). In 2019 she received the Outstanding Alumna Award from the Emory Alumni Association, and in 2020 the American Heart Association’s Eugene Braunwald Academic Mentoring Award. In 2021, the American Heart Association established the annual Dr. Nanette K. Wenger Award for the best scientific publication in cardiovascular disease in women. The American College of Cardiology conferred its Lifetime Achievement Award on Dr. Wenger in 2022. She also received a Lifetime Achievement Award from the World Heart Federation.

Dr. Wenger has participated as author of several American College of Cardiology/American Heart Association Clinical Practice Guidelines. She is past Chair, Board of Directors, Society for Women’s Health Research. Dr. Wenger serves on editorial boards of numerous professional journals and is a sought-after lecturer for issues related to heart disease in women, heart disease in the elderly, cardiac rehabilitation, coronary prevention, and contemporary cardiac care. She is listed in Best Doctors in America.

Dr. Wenger has authored or coauthored over 1700 scientific and review articles and book chapters.


About Ellen R. Gritz, PhD
Ellen R. Gritz, PhD is Professor Emerita at The University of Texas MD Anderson Cancer Center (9/2016-present). Formerly, Dr. Gritz was professor and Chair (7/1993-10/2014) of the Department of Behavioral Science until her retirement and served as Professor from 12/2014-8/2016. She is an established leader in cancer prevention and control research and an internationally known investigator. Dr. Gritz has published extensively on cigarette smoking behavior: prevention, cessation, pharmacologic mechanisms, and special issues of concern to women and high-risk groups, including ethnic minorities, youth, cancer patients and persons living with HIV/AIDS and other chronic illnesses. Other research includes areca nut/betel quid use and dependence in Asia, skin cancer prevention in children and high-risk individuals, genetic testing and counseling for hereditary cancers, and cancer survivorship.

Read Dr. Gritz Full Bio

Ellen R. Gritz, PhD is Professor Emerita at The University of Texas MD Anderson Cancer Center (9/2016-present). Formerly, Dr. Gritz was professor and Chair (7/1993-10/2014) of the Department of Behavioral Science until her retirement, and served as Professor from 12/2014-8/2016. She is an established leader in cancer prevention and control research and internationally known investigator. Dr. Gritz has published extensively on cigarette smoking behavior: prevention, cessation, pharmacologic mechanisms, and special issues of concern to women and high-risk groups, including ethnic minorities, youth, cancer patients and persons living with HIV/AIDS and other chronic illnesses. Other research includes areca nut/betel quid use and dependence in Asia, skin cancer prevention in children and high-risk individuals, genetic testing and counseling for hereditary cancers, and cancer survivorship. 

Dr. Gritz is a member of the National Academy of Medicine (formerly, The Institute of Medicine) and served as Chair, Section 11 (Social Sciences, Humanities, and Law). She is a member of The Academy of Medicine, Engineering and Science of Texas and served on the Board of Directors.  Dr. Gritz served as author and/or editor on eight Reports of the US Surgeon General on Smoking and Health. She served on the Board of Directors of the American Legacy Foundation, the large, non-profit public health foundation established as part of the Master Settlement Agreement, and was vice-chair of the board. She was president of both the Society for Research on Nicotine and Tobacco and the American Society of Preventive Oncology (ASPO). 

Dr. Gritz has received numerous awards and honors, including ASPO’s Joseph Cullen Memorial Award for outstanding research in smoking, ASPO’s Distinguished Achievement Award, MD Anderson’s Margaret and James Elkins, Jr. Faculty Achievement Award in Cancer Prevention, and the President’s Award for Faculty Excellence. She received the Alma Dea Morani Renaissance Woman Award honoring an outstanding physician or scientist, the Society of Behavioral Medicine, Cancer Special Interest Group’s Outstanding Biobehavioral Oncology Award, the Distinguished Professional Woman’s Award, UT Health Science Center-Houston, and Women in Science with Excellence (WISE). Dr. Gritz is a fellow of the Society of Behavioral Medicine and the American Psychological Association. She has over 300 publications, including journal articles, books, chapters and teaching aids. 

Dr. Gritz remains active in the National Academy of Medicine and in TAMEST, the Texas arm of the National Academies. In addition to professional activities, she serves on the Board of Directors of the Houston Grand Opera, and two committees of the Museum of Fine Arts, Houston (Asian arts, and arts of indigenous peoples - Latin America, Africa and Oceana). Dr. Gritz cultivates orchids and has a greenhouse with over 150 plants. She is an active, daily swimmer and she and her husband, Milton (Mickey) Rosenau Jr., avidly travel the world. They were formerly serious scuba divers (with 1200 dives each) and have travelled to Antarctica, the Northwest Passage, the Arctic (Svalbard, Greenland and Iceland), and the Seychelles on recent cruises.